A skin care expert who founded the first microbiome-focused skin care brand Gallinée would love to get stuck on the scientific backing of her probiotic products, but the consumer understanding just isn't there yet.
A clinical trial has found that Kerry Group’s probiotic strain Sporevia (Bacillus subtilis MB40) can eliminate Staphylococcus aureus in the human body by more than 95%.
Postbiotics are increasingly seen as an ideal focus for innovators in the world of microbiome modulation but hurdles are created by the lack of use of the word, by both consumers and the industry itself, according to industry experts at Probiota.
Future opportunities for probiotic innovation lie within combination ingredients, precision nutrition, and next-gen strains, according to Dr. Johanna Maukonon, director of global clinical innovation at IFF Health.
A probiotic blend can be effective in preserving or improving vaginal health, say Korean scientists as they demonstrate its role in alleviating the symptoms and severity of bacterial vaginosis (BV).
Berry researchers from around the world gathered last week at the 9th Biennial Berry Health Benefits Symposium in Tampa, FL to take a deep dive along the metabolic pathways in search of the microbes and metabolites that contribute to human health.
A scale-up company offering “the microbiome’s most powerful innovation platform” will attend NutraIngredients’ Probiota event next month (Feb 6-8) to showcase its pioneering technology to the gut health industry.
Calling all Probiotics, Prebiotics, and Microbiome start-ups!
NutraIngredients is on the hunt for entrepreneurial consumer-facing, science- or technology-based start-ups to join our Probiota Pioneers session and present their company in Barcelona.
Italian probiotics heavyweight Probiotical plans to bolster its presence in the US market by riding what the company calls a rising tide of consumer awareness of the importance of gut wellbeing to skin health.
Supplementation with Lacticaseibacillus rhamnosus GG (LGG) stimulates butyrate production and can minimise the severity of atopic dermatitis (AD) in children, say researchers.
Two senior leaders from probiotics heavyweights H&H Group, the owner of Swisse and Biostime among others, will be revealing the latest market trends and scientific developments in microbiome nutrition at our forthcoming Growth Asia Summit in Singapore.
Scientists have detailed a new approach for studying microbiota functionality that uses mass spectrometry to define protein levels in microbiota samples and identify specific cell function.
Sequential Skin has been awarded close to half a million euros as part of the Innovate UK SMART Grant to fund an initiative that advances understanding of the skin microbiome.
Consumers are increasingly aware of the detrimental effects of not getting enough sleep, and emerging links between the gut microbiota and sleep could create opportunities for prebiotics and probiotics in the booming natural sleep aid category.
A partnership between the UK’s Eagle Genomics and the Earlham Institute aims to generate deeper microbiome-based insights with the development of new microbiome multi-omics datasets and tools
Prebiotics are trending on multiple fronts right now, according to new research from Lumina Intelligence, as consumers look to improve their own health as well as their pets'.
Swedish probiotics firm BioGaia is to form a new investment subsidiary that looks to identify and invest in smaller companies that includes one developing products to strengthen the skin microbiome.
After a record-breaking 2020 Digital Summit, the IPA World Congress + Probiota Americas is back for 2021 with a dynamic extended program, a more immersive platform with new features, and more on-demand content.
Daily consumption of the fermented soy beverage Q-CAN induces a number of changes in the faecal and oral microbiome which can benefit our health, according to a new study.
With one week to go till Probiota, NutraIngredients took the opportunity to chat with one of the panellists for the event to hear his thoughts on where the industry is heading towards in the next few years.
British pharma company GlaxoSmithKline (GSK) are to pair up with Eligo Bioscience in a deal potentially worth €185m ($224m) that sees the firms target the microbiome to reduce the risk of developing acne.
Unilever’s Baby Dove wash and lotion has fallen foul of guidelines set by the UK’s ad watchdog, which ruled the product does not benefit the skin microbiome, unless proof can be presented.
A topical probiotic treatment can reduce eczema severity and increase quality of life for children as young as three, according to the results of an early, open-label study.
